Evidence map›Paper›PMID 30979116›Full record

ReviewPolymers2016

Biomedical Applications of Biodegradable Polyesters.

Iman Manavitehrani, Ali Fathi, Hesham Badr, Sean Daly, Ali Negahi Shirazi, Fariba Dehghani

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 495 citations in OpenAlex.

  1. Article
  2. Application of PLCL as a biodegradable polymer in biomedical engineering.Journal of materials science. Materials in medicine · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Iman ManavitehraniSchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia. iman6901@uni.sydney.edu.au.
Ali FathiSchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia. ali.fathi@sydney.edu.au.
Hesham BadrSchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia. hbad9313@uni.sydney.edu.au.
Sean DalySchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia. sean.daly@sydney.edu.au.
Ali Negahi ShiraziSchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia. ali.negahi@sydney.edu.au.
Fariba DehghaniSchool of Chemical and Biomolecular Engineering, University of Sydney, NSW 2006, Australia. fariba.dehghani@sydney.edu.au.
University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The focus in the field of biomedical engineering has shifted in recent years to biodegradable polymers and, in particular, polyesters. Dozens of polyester-based medical devices are commercially available, and every year more are introduced to the market. The mechanical performance and wide range of biodegradation properties of this class of polymers allow for high degrees of selectivity for targeted clinical applications. Recent research endeavors to expand the application of polymers have been driven by a need to target the general hydrophobic nature of polyesters and their limited cell motif sites. This review provides a comprehensive investigation into advanced strategies to modify polyesters and their clinical potential for future biomedical applications.

Indexed as

biodegradablemedical applicationspolyesterstissue engineering

Identifiers

PMID30979116
PMCPMC6432531
OpenAlexW2241227789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.